NCT07121868View on ClinicalTrials.gov

Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 3, 2024

Primary Completion Date

January 23, 2025

Study Completion Date

January 23, 2025

Conditions
Bioequivalence Study in Healthy Subjects
Interventions
DRUG

Test Product (Vocarzine)

hard capsule formulation

DRUG

Reference (R) Reagila ®

hard capsule formulation

Trial Locations (1)

Unknown

Advanced Research Center (ARC), Cairo

Sponsors
All Listed Sponsors
collaborator

Advanced Research Center (ARC)

UNKNOWN

collaborator

Atco Pharma for Pharmaceutical Industries

UNKNOWN

lead

Aya Mohammed Abdel Magid Abdel Hamid

OTHER

NCT07121868 - Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations | Biotech Hunter | Biotech Hunter